Compare IRON & WDFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRON | WDFC |
|---|---|---|
| Founded | 2017 | 1953 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.6B |
| IPO Year | N/A | N/A |
| Metric | IRON | WDFC |
|---|---|---|
| Price | $73.54 | $237.26 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 1 |
| Target Price | $110.08 | ★ $300.00 |
| AVG Volume (30 Days) | ★ 526.7K | 227.0K |
| Earning Date | 02-26-2026 | 01-08-2026 |
| Dividend Yield | N/A | ★ 1.71% |
| EPS Growth | N/A | ★ 26.07 |
| EPS | N/A | ★ 6.58 |
| Revenue | N/A | ★ $620,913,000.00 |
| Revenue This Year | N/A | $7.09 |
| Revenue Next Year | N/A | $6.02 |
| P/E Ratio | ★ N/A | $36.25 |
| Revenue Growth | N/A | ★ 2.86 |
| 52 Week Low | $30.82 | $175.38 |
| 52 Week High | $99.50 | $253.48 |
| Indicator | IRON | WDFC |
|---|---|---|
| Relative Strength Index (RSI) | 41.49 | 64.45 |
| Support Level | $76.00 | $199.43 |
| Resistance Level | $83.93 | $253.24 |
| Average True Range (ATR) | 4.20 | 6.93 |
| MACD | 0.20 | 2.10 |
| Stochastic Oscillator | 13.69 | 65.75 |
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
WD-40 Co is a global marketing organization focused on developing and selling products that solve maintenance and cleaning problems internationally. It offers two product groups: maintenance products, including the flagship WD-40 Multi-Use Product, which serves as a lubricant, rust preventative, penetrant, and moisture displacer, marketed globally; and homecare and cleaning products, mainly sold in North America, the UK, and Australia. The company distributes its products through hardware stores, automotive parts outlets, industrial suppliers, mass retailers, online platforms, and specialty retailers across the Americas, EIMEA, and Asia-Pacific, with the majority of revenue generated in the Americas.